Literature DB >> 23589280

Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.

J T Sandlund1, S A Shurtleff, M Onciu, E Horwitz, W Leung, V Howard, R Rencher, M E Conley.   

Abstract

X-linked lymphoproliferative syndrome (XLP) is caused by mutations in SH2D1A, and is associated with overwhelming infectious mononucleosis, aplastic anemia, hypogammaglobulinemia, and B-cell lymphomas. However, the frequency of SH2D1A mutations in males who present with B NHL is unknown. Five cases of XLP were diagnosed among 158 males presenting with B NHL (approximately 3.2%). Four of the patients had two episodes of B NHL and one had a single episode of B NHL followed by aggressive infectious mononucleosis. Prospective screening for XLP in males with B-cell lymphoma at the time of initial diagnosis should be considered.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  B cells; EBV; XLP; lymphoma

Mesh:

Substances:

Year:  2013        PMID: 23589280      PMCID: PMC4758190          DOI: 10.1002/pbc.24525

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.

Authors:  S B Murphy
Journal:  Semin Oncol       Date:  1980-09       Impact factor: 4.929

2.  Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).

Authors:  O Brandau; V Schuster; M Weiss; H Hellebrand; F M Fink; A Kreczy; W Friedrich; B Strahm; C Niemeyer; B H Belohradsky; A Meindl
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

3.  Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.

Authors:  M Morra; O Silander; S Calpe; M Choi; H Oettgen; L Myers; A Etzioni; R Buckley; C Terhorst
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

4.  The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.

Authors:  C Patte; A Auperin; J Michon; H Behrendt; G Leverger; D Frappaz; P Lutz; C Coze; Y Perel; M Raphaël; M J Terrier-Lacombe
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

Review 5.  X-linked lymphoproliferative syndromes: brothers or distant cousins?

Authors:  Alexandra H Filipovich; Kejian Zhang; Andrew L Snow; Rebecca A Marsh
Journal:  Blood       Date:  2010-07-26       Impact factor: 22.113

6.  Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.

Authors:  O Parolini; B Kagerbauer; I Simonitsch-Klupp; P Ambros; U Jaeger; G Mann; O A Haas; M Morra; H Gadner; C Terhorst; W Knapp; W Holter
Journal:  Ann Hematol       Date:  2002-07-20       Impact factor: 3.673

7.  Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

Authors:  D T Purtilo; D DeFlorio; L M Hutt; J Bhawan; J P Yang; R Otto; W Edwards
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

8.  Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.

Authors:  S B Murphy; W P Bowman; M Abromowitch; J Mirro; J Ochs; G Rivera; C H Pui; D Fairclough; C W Berard
Journal:  J Clin Oncol       Date:  1986-12       Impact factor: 44.544

9.  X-linked recessive progressive combined variable immunodeficiency (Duncan's disease).

Authors:  D T Purtilo; C K Cassel; J P Yang; R Harper
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

10.  X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.

Authors:  D T Purtilo; N Yasuda; H L Grierson; M Okano; B Brichacek; J Davis
Journal:  Princess Takamatsu Symp       Date:  1987
View more
  9 in total

1.  X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.

Authors:  Patrick R Blackburn; Wen-Lang Lin; David A Miller; Oswaldo Lorenzo-Betancor; Emily S Edwards; Michael T Zimmermann; Luca P Farrugia; William D Freeman; Alexandra I Soto; Ronald L Walton; Eric W Klee; Paldeep S Atwal; Roshini S Abraham; Daniel D Billadeau; Owen A Ross; Dennis W Dickson; James F Meschia
Journal:  J Neuropathol Exp Neurol       Date:  2019-05-01       Impact factor: 3.685

Review 2.  XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.

Authors:  Stuart G Tangye
Journal:  J Clin Immunol       Date:  2014-08-02       Impact factor: 8.317

Review 3.  How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.

Authors:  Ole Haagen Nielsen; Eric Charles LaCasse
Journal:  Genet Med       Date:  2016-07-14       Impact factor: 8.822

Review 4.  Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning.

Authors:  Elena Sieni; Valentina Cetica; Yvonne Hackmann; Maria Luisa Coniglio; Martina Da Ros; Benedetta Ciambotti; Daniela Pende; Gillian Griffiths; Maurizio Aricò
Journal:  Front Immunol       Date:  2014-04-16       Impact factor: 7.561

Review 5.  Germline mutations predisposing to diffuse large B-cell lymphoma.

Authors:  O C Leeksma; N F de Miranda; H Veelken
Journal:  Blood Cancer J       Date:  2017-02-17       Impact factor: 11.037

6.  Preimplantation Genetic Testing for a Chinese Family With X-Linked Lymphoproliferative Syndrome Type 1.

Authors:  Songchang Chen; Weihui Shi; Yeqing Qian; Liya Wang; Junyu Zhang; Shuyuan Li; Yiyao Chen; Chunxin Chang; Hongjun Fei; Lanlan Zhang; Hefeng Huang; Chenming Xu
Journal:  Front Genet       Date:  2020-11-04       Impact factor: 4.599

7.  Case Report: Novel Splicing Variant in SH2D1A in a Patient With X-Linked Lymphoproliferative Syndrome Type 1.

Authors:  Won Kyung Kwon; Jee Ah Kim; Jong-Ho Park; Doo Ri Kim; Su Eun Park; Yae Jean Kim; Keon Hee Yoo; Ja-Hyun Jang; Eun Suk Kang
Journal:  Front Pediatr       Date:  2022-03-23       Impact factor: 3.418

8.  Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report.

Authors:  Xiaodong Lyu; Zhen Guo; Yangwei Li; Ruihua Fan; Yongping Song
Journal:  BMC Med Genet       Date:  2018-04-12       Impact factor: 2.103

9.  Germline cytotoxic lymphocytes defective mutations in Chinese patients with lymphoma.

Authors:  Xue Chen; Yang Zhang; Fang Wang; Mangju Wang; Wen Teng; Yuehui Lin; Xiangping Han; Fangyuan Jin; Yuanli Xu; Panxiang Cao; Jiancheng Fang; Ping Zhu; Chunrong Tong; Hongxing Liu
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.